Latest Articles
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” - Oncology News Central
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” Oncology News Central
Published: Dec. 5, 2024, 12:54 p.m.
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” - oncologynewscentral.com
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” oncologynewscentral.com
Published: Dec. 5, 2024, 12:54 p.m.
How to deal with anxiety after cancer treatment - The Australian Women's Weekly
How to deal with anxiety after cancer treatment The Australian Women's Weekly
Published: Dec. 4, 2024, 11:17 p.m.
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update comes in li - Defense World
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update …
Published: Dec. 4, 2024, 8:10 a.m.
NMPA greenlights new endometrial cancer therapy - Investing.com India
NMPA greenlights new endometrial cancer therapy Investing.com India
Published: Dec. 4, 2024, 1:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News StockTitan
Published: Dec. 4, 2024, 12:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News StockTitan
Published: Dec. 4, 2024, midnight
Woman's Doctor: Know the symptoms of endometrial cancer - MSN
Woman's Doctor: Know the symptoms of endometrial cancer MSN
Published: Dec. 3, 2024, 8:37 p.m.
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer - OncLive
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer OncLive
Published: Dec. 3, 2024, 5:11 p.m.
Common condition linked with increased cancer and early death risks - Yahoo News UK
Common condition linked with increased cancer and early death risks Yahoo News UK
Published: Dec. 3, 2024, 1:12 p.m.
Link copied to clipboard!